New long-term partnership to address neurological disorder treatments
Category: News
Insight into double-blind, phase i/ii clinical trial for oesophageal cancer
New treatment option approved for women in Scotland
First car t-cell therapy accepted for second-line treatment in Scotland
Trial to evaluate safety and efficacy of MVA-BN vaccine
New initiatives to tackle AI-related challenges in life sciences
Phase 1 and 2 studies show promising results for anito-cel therapy
New therapy targets specific genetic alterations, promises extended survival
Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020